These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 25724945)
1. CD109 attenuates TGF-β1 signaling and enhances EGF signaling in SK-MG-1 human glioblastoma cells. Zhang JM; Murakumo Y; Hagiwara S; Jiang P; Mii S; Kalyoncu E; Saito S; Suzuki C; Sakurai Y; Numata Y; Yamamoto T; Takahashi M Biochem Biophys Res Commun; 2015 Apr; 459(2):252-258. PubMed ID: 25724945 [TBL] [Abstract][Full Text] [Related]
2. Processing of CD109 by furin and its role in the regulation of TGF-beta signaling. Hagiwara S; Murakumo Y; Mii S; Shigetomi T; Yamamoto N; Furue H; Ueda M; Takahashi M Oncogene; 2010 Apr; 29(15):2181-91. PubMed ID: 20101215 [TBL] [Abstract][Full Text] [Related]
3. CD109 release from the cell surface in human keratinocytes regulates TGF-β receptor expression, TGF-β signalling and STAT3 activation: relevance to psoriasis. Litvinov IV; Bizet AA; Binamer Y; Jones DA; Sasseville D; Philip A Exp Dermatol; 2011 Aug; 20(8):627-32. PubMed ID: 21539622 [TBL] [Abstract][Full Text] [Related]
4. Identification of CD109 as part of the TGF-beta receptor system in human keratinocytes. Finnson KW; Tam BY; Liu K; Marcoux A; Lepage P; Roy S; Bizet AA; Philip A FASEB J; 2006 Jul; 20(9):1525-7. PubMed ID: 16754747 [TBL] [Abstract][Full Text] [Related]
5. CD109: a multifunctional GPI-anchored protein with key roles in tumor progression and physiological homeostasis. Mii S; Enomoto A; Shiraki Y; Taki T; Murakumo Y; Takahashi M Pathol Int; 2019 May; 69(5):249-259. PubMed ID: 31219232 [TBL] [Abstract][Full Text] [Related]
6. Soluble CD109 binds TGF-β and antagonizes TGF-β signalling and responses. Li C; Hancock MA; Sehgal P; Zhou S; Reinhardt DP; Philip A Biochem J; 2016 Mar; 473(5):537-47. PubMed ID: 26621871 [TBL] [Abstract][Full Text] [Related]
7. Proteolytic cleavage of the TGFβ co-receptor CD109 changes its conformation, resulting in protease inhibition via activation of its thiol ester, and dissociation from the cell membrane. Jensen KT; Nielsen NS; Viana Almeida A; Thøgersen IB; Enghild JJ; Harwood SL FEBS J; 2024 Jul; 291(14):3169-3190. PubMed ID: 38587194 [TBL] [Abstract][Full Text] [Related]
8. CD109 acts as a gatekeeper of the epithelial trait by suppressing epithelial to mesenchymal transition in squamous cell carcinoma cells in vitro. Zhou S; da Silva SD; Siegel PM; Philip A Sci Rep; 2019 Nov; 9(1):16317. PubMed ID: 31695056 [TBL] [Abstract][Full Text] [Related]
9. CD109 regulates in vivo tumor invasion in lung adenocarcinoma through TGF-β signaling. Taki T; Shiraki Y; Enomoto A; Weng L; Chen C; Asai N; Murakumo Y; Yokoi K; Takahashi M; Mii S Cancer Sci; 2020 Dec; 111(12):4616-4628. PubMed ID: 33007133 [TBL] [Abstract][Full Text] [Related]
10. Transforming growth factor-β1 induces EMT by the transactivation of epidermal growth factor signaling through HA/CD44 in lung and breast cancer cells. Li L; Qi L; Liang Z; Song W; Liu Y; Wang Y; Sun B; Zhang B; Cao W Int J Mol Med; 2015 Jul; 36(1):113-22. PubMed ID: 26005723 [TBL] [Abstract][Full Text] [Related]
11. Suppression of skin tumorigenesis in CD109-deficient mice. Sunagawa M; Mii S; Enomoto A; Kato T; Murakumo Y; Shiraki Y; Asai N; Asai M; Nagino M; Takahashi M Oncotarget; 2016 Dec; 7(50):82836-82850. PubMed ID: 27756876 [TBL] [Abstract][Full Text] [Related]
12. Association of down-regulation of CD109 expression with up-expression of Smad7 in pathogenesis of psoriasis. Liu XX; Feng AP; He YM; Li Y; Wu Y; Lian X; Hu F; Li JW; Tu YT; Chen SJ J Huazhong Univ Sci Technolog Med Sci; 2016 Feb; 36(1):132-136. PubMed ID: 26838754 [TBL] [Abstract][Full Text] [Related]
13. CD109-mediated degradation of TGF-β receptors and inhibition of TGF-β responses involve regulation of SMAD7 and Smurf2 localization and function. Bizet AA; Tran-Khanh N; Saksena A; Liu K; Buschmann MD; Philip A J Cell Biochem; 2012 Jan; 113(1):238-46. PubMed ID: 21898545 [TBL] [Abstract][Full Text] [Related]
14. Overexpression of CD109 in the Epidermis Differentially Regulates ALK1 Versus ALK5 Signaling and Modulates Extracellular Matrix Synthesis in the Skin. Vorstenbosch J; Nguyen CM; Zhou S; Seo YJ; Siblini A; Finnson KW; Bizet AA; Tran SD; Philip A J Invest Dermatol; 2017 Mar; 137(3):641-649. PubMed ID: 27866969 [TBL] [Abstract][Full Text] [Related]
15. The TGF-β co-receptor, CD109, promotes internalization and degradation of TGF-β receptors. Bizet AA; Liu K; Tran-Khanh N; Saksena A; Vorstenbosch J; Finnson KW; Buschmann MD; Philip A Biochim Biophys Acta; 2011 May; 1813(5):742-53. PubMed ID: 21295082 [TBL] [Abstract][Full Text] [Related]
16. CD109, a negative regulator of TGF-β signaling, is a putative risk marker in diffuse large B-cell lymphoma. Yokoyama M; Ichinoe M; Okina S; Sakurai Y; Nakada N; Yanagisawa N; Jiang SX; Numata Y; Umezawa A; Miyazaki K; Higashihara M; Murakumo Y Int J Hematol; 2017 May; 105(5):614-622. PubMed ID: 28032275 [TBL] [Abstract][Full Text] [Related]
17. CD109 is a component of exosome secreted from cultured cells. Sakakura H; Mii S; Hagiwara S; Kato T; Yamamoto N; Hibi H; Takahashi M; Murakumo Y Biochem Biophys Res Commun; 2016 Jan; 469(4):816-22. PubMed ID: 26707640 [TBL] [Abstract][Full Text] [Related]
18. The GPI-anchored protein CD109 protects hematopoietic progenitor cells from undergoing erythroid differentiation induced by TGF-β. Tanabe M; Hosokawa K; Nguyen MAT; Nakagawa N; Maruyama K; Tsuji N; Urushihara R; Espinoza L; Elbadry MI; Mohiuddin M; Katagiri T; Ono M; Fujiwara H; Chonabayashi K; Yoshida Y; Yamazaki H; Hirao A; Nakao S Leukemia; 2022 Mar; 36(3):847-855. PubMed ID: 34743190 [TBL] [Abstract][Full Text] [Related]
19. CD109 mediates tumorigenicity and cancer aggressiveness via regulation of EGFR and STAT3 signalling in cervical squamous cell carcinoma. Mo XT; Leung TH; Tang HW; Siu MK; Wan PK; Chan KK; Cheung AN; Ngan HY Br J Cancer; 2020 Sep; 123(5):833-843. PubMed ID: 32507856 [TBL] [Abstract][Full Text] [Related]